↓ Skip to main content

Oncotarget

Genomic loss of heterozygosity and survival in the REAL3 trial

Overview of attention for article published in Oncotarget, November 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
14 Dimensions

Readers on

mendeley
25 Mendeley
Title
Genomic loss of heterozygosity and survival in the REAL3 trial
Published in
Oncotarget, November 2018
DOI 10.18632/oncotarget.26336
Pubmed ID
Authors

Elizabeth C. Smyth, Catherine Cafferkey, Andrea Loehr, Tom Waddell, Ruwaida Begum, Clare Peckitt, Thomas C. Harding, Minh Nguyen, Alicia F. Okines, Mitch Raponi, Sheela Rao, David Watkins, Naureen Starling, Gary W. Middleton, Jonathan Wadsley, Wasat Mansoor, Tom Crosby, Andrew Wotherspoon, Ian Chau, David Cunningham

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 25 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 25 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 24%
Student > Ph. D. Student 4 16%
Student > Doctoral Student 2 8%
Other 2 8%
Student > Bachelor 2 8%
Other 4 16%
Unknown 5 20%
Readers by discipline Count As %
Medicine and Dentistry 11 44%
Biochemistry, Genetics and Molecular Biology 3 12%
Agricultural and Biological Sciences 2 8%
Psychology 1 4%
Pharmacology, Toxicology and Pharmaceutical Science 1 4%
Other 0 0%
Unknown 7 28%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 08 January 2019.
All research outputs
#15,690,772
of 23,316,003 outputs
Outputs from Oncotarget
#6,776
of 14,403 outputs
Outputs of similar age
#266,303
of 438,444 outputs
Outputs of similar age from Oncotarget
#67
of 124 outputs
Altmetric has tracked 23,316,003 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 14,403 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.7. This one is in the 45th percentile – i.e., 45% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,444 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 30th percentile – i.e., 30% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 124 others from the same source and published within six weeks on either side of this one. This one is in the 40th percentile – i.e., 40% of its contemporaries scored the same or lower than it.